As of January 22, 2025, RAPT Therapeutics (RAPT) has a market cap of $42.649 million USD. According to our data, RAPT Therapeutics is ranked No.8250 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $42.65 M |
-22.78%
|
Dec 31, 2024 | $55.23 M |
-93.64%
|
Dec 29, 2023 | $0.87 B |
25.51%
|
Dec 30, 2022 | $0.69 B |
-46.09%
|
Dec 31, 2021 | $1.28 B |
85.97%
|
Dec 31, 2020 | $0.69 B |
-28.47%
|
Dec 31, 2019 | $0.97 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
Alkermes
ALKS
|
$4.89 B |
-0.000 M
|
Ireland
|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Exelixis
EXEL
|
$9.39 B |
0.000 M
|
USA
|
MacroGenics
MGNX
|
$0.19 B |
-0.000 M
|
USA
|
Nektar Therapeutics
NKTR
|
$0.17 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
TG Therapeutics
TGTX
|
$4.54 B |
0.000 M
|
USA
|
Xencor
XNCR
|
$1.45 B |
0.000 M
|
USA
|
Market Cap | = | RAPT Stock Price | * | RAPT Shares Outstanding |
= | $1.22 | * | 34.96 M | |
= | $42.65 M |